Search
for
Sort by
Research 61–90 of 1000+
- Polycystic Ovary Syndrome: A Common Reproductive and Metabolic Disorder Necessitating Early Recognition and Treatment
- No metabolic impact of surgical normalization of hyperandrogenism in postmenopausal women with ovarian androgen-secreting tumours
- Co-administration of 5α-reductase Inhibitors Worsens the Adverse Metabolic Effects of Prescribed Glucocorticoids
- Vitamin D, Lipid Metabolism and Prostate Cancer
- Decline of life’s energy theory of ageing 1. Revitalisation of energy metabolism and ageing mitochondria
- ARTIFICIAL INTELLIGENCE AND THE DIAGNOSTIC INVISIBILITY OF WOMEN’S METABOLIC DISORDERS: A NARRATIVE REVIEW OF SOCIO-TECHNICAL CHALLENGES IN PCOS/PMOS RECOGNITION
- Photo-downregulation of SIRT4 mitigates aging in mice by enhancing H3K9ac via fatty acid metabolism
- Analysis of metabolic characteristics of epristeride in zebrafish based on LC-Q-TOF MS and its potential applications in doping control
- The investigation of insulin resistance and metabolic syndrome in male patients with early-onset androgenetic alopecia
- The metabolic syndrome- associated small G protein ARL15 plays a role in adipocyte differentiation and adiponectin secretion
- Role of skin enzymes in metabolism of topical drugs
- Polycystic ovary syndrome: a complex condition with psychological, reproductive and metabolic manifestations that impacts on health across the lifespan
- Potential role and therapeutic interests of myo-inositol in metabolic diseases
- Metabolic features of the reproductive phenotypes of polycystic ovary syndrome
- Metabolic risk in PCOS: phenotype and adiposity impact
- Low sex hormone-binding globulin is associated with low high-density lipoprotein cholesterol and metabolic syndrome in women with PCOS
- Impact of Treatment with Rosiglitazone or Metformin on Biomarkers for Insulin Resistance and Metabolic Syndrome in Patients with Polycystic Ovary Syndrome
- Elevated fasting insulin is associated with cardiovascular and metabolic risk in women with polycystic ovary syndrome
- Gynecologic and andrologic dermatology and the metabolic syndrome
- Metabolic and transcriptomic reprogramming during contact inhibition-induced quiescence is mediated by YAP-dependent and YAP-independent mechanisms
- Chromium supplementation does not improve weight loss or metabolic and hormonal variables in patients with polycystic ovary syndrome: A systematic review
- Persistent Poor Metabolic Profile in Postmenopausal Women With Ovarian Hyperandrogenism After Testosterone Level Normalization
- Variations in alanine aminotransferase levels within the normal range predict metabolic and androgenic phenotypes in women of reproductive age
- Evaluation of metabolic and hormonal parameters in women with PCOS living in Black Sea Region
- Skin as a Window to Endocrine Dysfunction: Dermatological and Metabolic Interactions in Polycystic Ovary Syndrome
- Cardiovascular and Metabolic Risk Profiles Across Different Phenotypes of Polycystic Ovary Syndrome
- Metabolic dysfunction-associated steatotic liver disease is associated with androgenetic alopecia in adults with stronger effects in women and unhealthy lifestyles
- Metabolic Aspects of Polycystic Ovary Syndrome
- Metabolic Aspects of Polycystic Ovary Syndrome
- Animal Models and the Developmental Origins of Polycystic Ovary Syndrome: Increasing Evidence for the Role of Androgens in Programming Reproductive and Metabolic Dysfunction